Inhibitor Therapeutics, Inc. Annual Interest Expense in USD from 2013 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Inhibitor Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from 2013 to 2022.
  • Inhibitor Therapeutics, Inc. Interest Expense for the quarter ending December 31, 2022 was $3.36K.
  • Inhibitor Therapeutics, Inc. Interest Expense for the twelve months ending December 31, 2022 was $23.2K.
  • Inhibitor Therapeutics, Inc. annual Interest Expense for 2022 was $23.2K, a 56.6% increase from 2021.
  • Inhibitor Therapeutics, Inc. annual Interest Expense for 2021 was $14.8K.
  • Inhibitor Therapeutics, Inc. annual Interest Expense for 2014 was $37.5K, a 1849% increase from 2013.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $23.2K +$8.4K +56.6% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-29
2021 $14.8K Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2014 $37.5K +$35.6K +1849% Jan 1, 2014 Dec 31, 2014 10-K 2016-02-01
2013 $1.92K Jan 1, 2013 Dec 31, 2013 10-K 2015-02-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.